Biorbis

The world’s first and only antibody event designed by you…

Heiner Apeler Director, Molecular and Antibody Biology Bayer Schering Pharma	Alain Beck Head of Physico Chemistry Department Pierre Fabre	William Strohl Vice President, Biologics Research Johnson & Johnson
Tariq Ghayur Senior Principal Scientist and Research Fellow Abbott Laboratories	Andrew McKnight Research Fellow Pfizer	David Blakey Chief Scientist, Oncology AstraZeneca
Andy Popplewell Director, V-Region Discovery and Engineering UCB Celltech	Andreas Plückthun Professor of Biochemistry University of Zurich	Robert Beckman Executive Director, Clinical Research Oncology Daiichi-Sankyo
Paul Parren Senior Vice President, Research and Preclinical Development Genmab	David Shen Executive Director Merck Biologics Research	Alexey Teplyakov Senior Research Scientist Johnson & Johnson Biologics Research
Christian Klein Head of Oncology Programs Roche GlycArt	Laurent Audoly Senior Director Merck Bioventures	Dr Aziz Cayli Chief Executive Officer Cellca GmbH
Dr Ryan N. Fiorini Chief Operating Officer Immunologix, Inc.	Søren Bregenholt, Ph.D Head of Preclinical R&D, Symphogen A/S.
Satish Singh, Research Fellow, Pfizer Sarah Fredriksson, Chief Executive Officer, Genovis Hitto Kaufmann, Director, Upstream Development, Boehringer Ingelheim Claire Dobson, Head of Display Technology, MedImmune Søren Bregenholt, Chief Operating Officer, Symphogen Juqun Shen, Senior Group Leader, Department of Antibody Technology, ImClone Systems (an Eli Lilly subsidiary) Dale Ludwig, Vice President, ImClone Systems (a wholly owned subsidiary of Eli Lilly) Thomas Waldmann, Science and Technology Applications, Sloning BioTechnology Roland Buelow, Founder and Chief Executive Officer, Open Monoclonal Antibody Teodor Aastrup, Chief Executive Officer, Attana

The Biorbis Antibody Engineering and Design conference is a new breed of antibody meeting, different to any other you've experienced.

Because it's been designed by you.

It's been designed by people from companies like Genentech, MedImmune, Roche, Abbott, Johnson & Johnson, Biogen Idec, Merck, UCB Celltech, Pfizer and many other big pharmaceutical companies and innovative biotechs.

Why attend?

Shorn of tired case studies and company overviews, the focus is on delivering practical value to your antibody drug development activities.

Covering challenges and opportunities identified by you, you'll leave this meeting with a raft of new ideas and contacts to take back to your organization.

Hear speakers talk about overcoming problems you're facing with a level of frankness and sincerity you can't get from any other antibody event.

Meet innovative scientists and research leaders from big pharma and large biotech, and understand how they meet the challenges associated with engineering and designing more effective antibody drugs.

What's on the agenda?

Here are just some of topics covered on the agenda:

• Engineering antibodies with enhanced characteristics. Isotype choice, half life, stability, efficacy, immunogenicity, using structural insights and more…
• Utilizing structural-based drug design. How to enhance structural understanding, epitope mapping and using crystallization studies to improve subsequent development
• Reduction of manufacturing risk and improving expression early in the development process
• How to ensure appropriate species cross-reactivity
• How to improve anti-tumour activity through better antibody design. The thoughts of several of the world's leading oncology experts and case studies
• Generation of multivalent antibodies and use combinatorial strategies to combat cancer
• Discovery of suitable antibody candidates and identification new targets via novel strategies

1-2-1 Partnering

We work harder than any other meeting organizer to put you in front of the individuals you want to meet, providing personal introductions and a host of other networking opportunities including:

• Speed networking – Meet up to 50 other attendees in a one hour session. Introduce yourself to potential partners, collaborators and clients.
• Over 8 hours of networking time built into the agenda
• Innovative masterclasses providing you with the chance to get tailored solutions to the challenges you're facing.
• Panel discussion – interactive Q&A sessions giving you an opportunity to join the discussion.